Quarterly Report • Nov 15, 2024
Quarterly Report
Open in ViewerOpens in native device viewer


1
In beauƟful Hardanger we have access to the cleanest freshwater from the nearby lake and unlimited fresh seawater from the łord
2
BioFish is a Norwegian independent producer of high-quality smolt and postsmolt. The company has a RAS producƟon facility in Ljones close to the Hardangerłord on the west coast of Norway. Numerous Norwegian fish farming sites are located within one day of transport.
BioFish was established in 2016 and has its own uniquely built facility where the fish health and water environment has been in focus through all the decisions during building the producƟon facility.
BioFish holds an aquaculture license for 5 million smolt and a discharge license for 2,200 tons.
| Strong demand from large industry players for batches to be delivered in o 2025-2026 |
|||||
|---|---|---|---|---|---|
| KEY FIGURES | |||||
| Amounts in NOK 1,000 | Q3 24 | Q3 23 | YTD 24 | YTD 23 | 2023 |
| Total revenue | 19 477 | 27 576 | 36 666 | 47 684 | 47 684 |
| Operating expenses excl. depr. | 16 739 | 15 869 | 41 248 | 43 073 | 57 090 |
| Operating result (EBITDA) | 2 738 | 11 707 | -4 583 | 4 611 | -9 406 |
| Depreciation | 3 182 | 3 000 | 9 514 | 3 250 | 6 250 |
| Result before tax | -2 411 | 8 083 | -19 114 | 785 | -17 825 |
| Tax expense | - | - | - | - | -313 |
| Result for the period | -2 411 | 8 083 | -19 114 | 785 | -17 512 |
| Interest-bearing debt | 50 000 | 53 000 | 50 000 | 53 000 | 52 000 |
| Equity ratio (%) | 70.9 | 76.3 | 70.9 | 76.3 | 75.2 |
| Net cash flow from operations | -4 081 | 10 072 | -12 674 | 1 387 | -19 143 |

The company delivered 159 tons of smolt in the quarter, resulƟng in total revenue of NOK 19.5 million. In the comparable period of 2023, the company delivered 250 tons, which generated NOK 27.6 million in revenue.
Volumes sold in the third quarter were impacted by one delivery of 86 tons, which was rescheduled from September (Q3) to October (Q4). In addiƟon, one customer asked for earlier delivery, which implied lower average weight on this batch.
For the year-to-date period, revenues were NOK 36.7 million from the delivery of a total of 365 tons of smolt. For the comparable period in 2023, the company delivered 450 tons of smolt, which generated NOK 47.7 million in revenues.
Cost of goods sold totalled NOK 12.3 million in the quarter. This represents a slight increase from NOK 12.1 million in the prior-year period.
For the period to date, cost of goods sold totalled NOK 23.6 million, compared with NOK 35.7 million in the prior-year period.
Total expenses in the third quarter were NOK 19.9 million, compared with NOK 18.9 million in the third quarter of 2023. The increase was mainly driven by higher depreciaƟon. DepreciaƟon charges were NOK 3.2 million in the quarter compared with NOK 3.0 million in the same period of 2023.
Total expenses for the period to date were NOK 50.8 million, compared with NOK 46.3 million in 2023.
Net financial costs were NOK 2.0 million in the quarter, compared with NOK 0.6 million in the prior-year period. The increase was driven by reduced capitalisaƟon of interest expenses.
For the year-to-date period, net financial costs were NOK 5.0 million, compared with NOK 0.6 million last year.
The company had no tax expenses in the quarter or in the first nine months of 2024, nor in the third quarter of 2023.
The result for the quarter ended at negaƟve NOK 2.4 million, compared with a profit of NOK 8.1 million in the same period last year.
The result for the period to date was negaƟve NOK 19.1 million, compared with a profit of NOK 0.8 million in the same period of 2023.
Cash and cash equivalents were NOK 0.4 million at the end of the quarter, compared with NOK 3.5 million at the end of June 2024 and down from NOK 1.3 million at year-end 2023.
At the end of the period, interest-bearing debt was NOK 50.0 million, compared with NOK 51.0 million at the end of the previous quarter and NOK 52.0 million at year-end 2023.
Total equity at 30 September 2024 was NOK 190.4 million, resulƟng in an equity raƟo of 70.9 per cent, compared with NOK 192.8 million at the end of the June 2024, and NOK 195.0 million at year-end 2023.
Cash flow from operaƟons was negaƟve NOK 4.1 million, compared with posiƟve NOK 10.1 million in same period of 2023. Build-up of biomass in the facility and no capitalisaƟon of expenses were the main reasons for the negaƟve change in cash flow.
For the year-to-date period, cash flow from operaƟons was negaƟve NOK 12.7 million, compared with posiƟve NOK 1.4 million in same period of 2023.
Investments in the facility and related machinery totalled NOK 1.0 million in the third quarter, and NOK 5.7 million in the first nine months, and were mainly related to the capacity expansion of the producƟon faciliƟes.

Net cash flow from financing acƟviƟes ended at posiƟve NOK 2.0 million in the quarter, as a result of increased use of the bank overdraŌ facility, compared with negaƟve NOK 0.4 million in the third quarter 2023.
For the three quarters to date, cash flow from financing of posiƟve NOK 17.5 million included net proceeds from new equity of NOK 14.5 million arising from the exercise of warrants.
Net cash flow for the third quarter ended at negaƟve NOK 3.1 million, compared with posiƟve NOK 4.2 million in the third quarter of 2023.
Net cash flow for the period to date ended at negaƟve NOK 0.9 million, down from NOK 25.4 million in the same period of 2023, where NOK 69.0 million were raised in a private placement.
In November, it was decided to reschedule delivery of one of the two November batches to March 2025, in order to meet customers requirements.
All remaining volumes for 2024 have been sold.
With a good track record in terms of biological performance, BioFish is an aƩracƟve supplier of high-quality, healthy smolt and post-smolt. Geographically, BioFish is ideally located in an area with high density of salmon farmers.
Demand for smolt and post-smolt remains strong overall, but the "traffic light regulaƟon" requires a six per cent producƟon cut for fish farmers in our region, impacƟng short-term demand and Ɵming of delivery. For BioFish, this affects one of the two November batches (~60 tons), which has been moved to March 2025.
Despite capacity reducƟon in our region, demand for BioFish's high-quality smolt remains solid, driven by its track-record of strong biological performance. The capacity reducƟon in our region means farmers must opƟmise producƟon, seƫng stricter requirements for robust smolt. Recently, major industry players have shown strong interest in BioFish's smolt and post-smolt batches for the coming years.
Customer preferences and market dynamics have impacted the projected sales volume for 2024. In addiƟon, legacy operaƟonal challenges at the site relaƟng to past performance have impacted producƟon in 2024, although these challenges have been addressed and are in process of being resolved. In sum, sales projecƟons have been adjusted to ~500-550 tons for the full-year period. For 2025, sales volumes are expected to increase to 900-1,100 tons, supported by firm orders and ongoing tenders from top-Ɵer fish farmers.
Torbjørn Gjelsvik Chair
Margrethe Sæbø Smith Director
Bent-Are Brunes Ratvik Director
KjeƟl Grønskag Director
Jens-Julius Ramdahl Nygaard Director
Sondre Hagerup Johnsrud Chief ExecuƟve Officer

| CONSOLIDATED INCOME STATEMENT | ||||||
|---|---|---|---|---|---|---|
| (Unaudited figures in NOK 1,000) | Note | 3Q 24 | 3Q 23 | YTD 24 | YTD 23 | 2023 |
| Total revenue | 19 477 | 27 576 | 36 666 | 47 684 | 47 684 | |
| Cost of goods sold | 12 298 | 12 064 | 23 621 | 35 704 | 42 830 | |
| Salaries and personnel expenses | 2 812 | 2 053 | 11 452 | 3 445 | 7 564 | |
| Other operating expenses | 1 629 | 1 752 | 6 175 | 3 924 | 6 696 | |
| Total expenses | 16 739 | 15 869 | 41 248 | 43 073 | 57 090 | |
| Operating result (EBITDA) | 2 738 | 11 707 | -4 583 | 4 611 | -9 406 | |
| Depreciation | 2 | 3 182 | 3 000 | 9 514 | 3 250 | 6 250 |
| Operating result (EBIT) | -444 | 8 707 | -14 097 | 1 361 | -15 656 | |
| Net interest expenses | -1 995 | 235 | -5 052 | 187 | -1 770 | |
| Net agio | 27 | 389 | 34 | 389 | -399 | |
| Net financial items | -1 967 | -624 | -5 018 | -576 | -2 169 | |
| Result before tax | -2 411 | 8 083 | -19 114 | 785 | -17 825 | |
| Tax expense | 8 | - | - | - | - | -313 |
| Result for the period | -2 411 | 8 083 | -19 114 | 785 | -17 512 |

| CONSOLIDATED STATEMENT OF FINANCIAL POSITION | |||||
|---|---|---|---|---|---|
| (Unaudited figures in NOK 1,000) | |||||
| Note | 30.09.2024 | 30.06.2024 | 31.12.2023 | 30.09.2023 | |
| ASSETS | |||||
| Total intangible assets | 8 | - | - | - | - |
| Total tangible fixed assets | 2 | 229 696 | 231 835 | 233 546 | 232 658 |
| Total non-current assets | 229 696 | 231 835 | 233 546 | 232 658 | |
| Biological assets | 3 | 20 975 | 18 283 | 11 998 | 12 273 |
| Other inventories | 5 003 | 1 556 | 486 | 1 171 | |
| Account receivables | 10 584 | - | - | 3 297 | |
| Other receivables | 1 879 | 1 647 | 11 948 | 1 680 | |
| Cash and cash equivalents | 410 | 3 528 | 1 281 | 28 281 | |
| Total current assets | 38 851 | 25 013 | 25 713 | 46 702 | |
| TOTAL ASSETS | 268 547 | 256 848 | 259 259 | 279 360 | |
| 30.09.2024 | 30.06.2024 | 31.12.2023 | 30.09.2023 | ||
| EQUITY AND LIABILITIES | |||||
| Paid in equity | 5 | 227 190 | 226 844 | 212 326 | 212 326 |
| Earned equity | -36 840 | -34 082 | -17 379 | 918 | |
| Total equity | 4 | 190 350 | 192 762 | 194 947 | 213 244 |
| Long term debt Loans from credit institutions |
6 | 50 000 | 51 000 | 52 000 | 53 000 |
| Total other long term debt | 50 000 | 51 000 | 52 000 | 53 000 | |
| Short term debt | |||||
| Bank overdraft | 7 | 10 000 | 5 000 | - | - |
| Account payables | 12 567 | 5 224 | 9 253 | 7 977 | |
| Public duties | 532 | 795 | 288 | 3 192 | |
| Other short-term liabilities Total short-term debt |
5 098 28 197 |
2 067 13 086 |
2 771 12 312 |
1 947 13 116 |
|
| Total debt | 78 197 | 64 405 | 64 312 | 66 116 | |
| TOTAL EQUITY AND DEBT | 268 547 | 256 848 | 259 259 | 279 360 |

| CONSOLIDATED STATEMENT OF CASH FLOWS (Unaudited figures in NOK 1,000) |
|||||
|---|---|---|---|---|---|
| 3Q 24 | 3Q 23 | YTD 24 | YTD 23 | 2023 | |
| Cash flows from operating activities | |||||
| Result before tax | -2 411 | 8 083 | -19 114 | 785 | -17 825 |
| Depreciation | 3 182 | 3 000 | 9 514 | 3 250 | 6 250 |
| Change in inventory and biological assets | -6 140 | 2 453 | -13 494 | 6 967 | 7 927 |
| Change in account receivables | -10 584 | -3 297 | - 10 584 |
-3 247 | 50 |
| Change in account payables | 7 343 | -6 452 | 3 314 | -6 504 | -5 228 |
| Items reclassified as financing activities | 1 995 | 235 | 5 052 | 187 | 1 770 |
| Other changes | 2 534 | 6 050 | 12 638 | -51 | -12 087 |
| Net cash flows from operating activities | -4 081 | 10 072 | -12 674 | 1 387 | -19 143 |
| Cash flows from investing activities | |||||
| Net investment in fixed assets | -1 043 | -5 517 | -5 663 | -41 742 | -45 630 |
| Net cash flows from investing activities | -1 043 | -5 517 | -5 663 | -41 742 | -45 630 |
| Cash flows from financing activities | |||||
| Repayment of long term debt | - 1 000 |
- | -2 000 | -3 000 | -4 000 |
| Change in bank overdraft | 5 000 | - | 10 000 | - | - |
| New equity | - | -118 | 14 518 | 68 985 | 68 986 |
| Net interest expenses | -1 995 | -235 | -5 052 | -187 | -1 770 |
| Net cash flows from financing activities | 2 005 | -353 | 17 466 | 65 798 | 63 216 |
| Net cash flows for the period | -3 118 | 4 202 | -871 | 25 443 | -1 557 |
| Cash at the beginning of period | 3 528 | 24 079 | 1 281 | 2 838 | 2 838 |
| Cash at the end of period | 410 | 28 281 | 410 | 28 281 | 1 281 |

The interim consolidated financial statements do not include all the information and disclosures required by NGAAP in the annual financial statements and should be read in conjunction with the Group´s Annual Financial Statements 2023. 2024 2023
| Note 1: Accounting principles | |||
|---|---|---|---|
| for small enterprises and NRS 11. | This report is prepared according to Norwegian Generally Accepted Accounting Principles (NGAAP) standard | ||
| 2023. | The interim consolidated financial statements do not include all the information and disclosures required by NGAAP in the annual financial statements and should be read in conjunction with the Group´s Annual Financial Statements |
||
| All amounts are in NOK 1 000 if not otherwise stated. | |||
| All figures are unaudited, except for year-end figures (last year). | |||
| Note 2 - Fixed assets | |||
| 2024 | 2023 | ||
| Opening balance 1.1. | 233 546 | 193 916 | |
| Additions | 5 663 | 41 992 | |
| Disposals | - | - | |
| Depreciation* | -9 514 | -3 250 |
In 1Q 2023, BioFish entered into an agreement to acquire 100% of the shares in Biofish Land AS (to be incorporated) from the Seller Biofish Aquafarms AS, a company that owns the land where the BioFish facility is located. The transacƟon has taken longer than anƟcipated and will be seƩled through the issuance of 8.5 million shares, 8.5 million warrants and repayment of net debt of approximately NOK 3.9 million in Biofish Land AS. The transacƟon is in the final stages of being finalised. Paid in Earned capital equity TOTAL
| In 1Q 2023, BioFish entered into an agreement to acquire 100% of the shares in Biofish Land AS (to be incorporated) from the Seller Biofish Aquafarms AS, a company that owns the land where the BioFish facility is located. The transacƟon has taken longer than anƟcipated and will be seƩled through the issuance of 8.5 million shares, 8.5 million warrants and repayment of net debt of approximately NOK 3.9 million in Biofish Land AS. The transacƟon is in the final stages of being finalised. |
||||||
|---|---|---|---|---|---|---|
| Note 3 - Biological assets | ||||||
| BioFish recognises and measures biological assets (smolt) at cost. Cost on stock is historic costs after expensed mortality. |
||||||
| Note 4 – Equity | ||||||
| Paid in | Earned | |||||
| capital | equity | TOTAL | ||||
| Equity at 1.1.24 | 212 326 | -17 379 | 194 947 | |||
| Net result for the period | -19 114 | -19 114 | ||||
| New equity (net of expenses) | 14 518 | - | 14 518 | |||
| Equity at 30.9.24 | 226 844 | -36 493 | 190 351 | |||
| Equity at 1.1.23 | 143 340 | 134 | 143 474 | |||
| Net result for the period | - | 785 | 785 | |||
| New equity (net of expenses) | 68 985 | - | 68 985 | |||
| Equity at 30.9.23 | 212 325 | 919 | 213 244 | |||
| 9 | ||||||

| Note 5 - Share capital and shareholder information | |||
|---|---|---|---|
| Shareholder Awilco AS |
Number of shares 15 281 946 |
Shareholding 15.02 % |
|
| Odfjell Land AS | 12 734 686 | 12.52 % | |
| Stoksund AS | 10 141 000 | 9.97 % | |
| Helgø Invest AS | 3 305 000 | 3.25 % | |
| Monaco Invest AS | 3 200 000 | 3.15 % | |
| Yme Fish AS | 3 200 000 | 3.15 % | |
| Tigerstaden Marine AS | 3 000 000 | 2.95 % | |
| UBS Switzerland AG | 2 797 999 | 2.75 % | |
| Biofish Aquafarm AS | 2 700 696 | 2.65 % | |
| Skulstad | 2 527 410 | 2.48 % | |
| Profond AS | 2 462 080 | 2.42 % | |
| Asteroidebakken AS | 2 401 254 | 2.36 % | |
| Jaras Invest AS | 2 233 996 | 2.20 % | |
| Yme Holding AS | 2 215 571 | 2.18 % | |
| Nordnet Livsforsikring AS | 2 000 000 | 1.97 % | |
| Millennium Falcon AS | 1 744 665 | 1.71 % | |
| Nordnet Bank AB | 1 706 690 | 1.68 % | |
| Trapesa AS | 1 238 945 | 1.22 % | |
| VH Eiendom & Invest AS | 851 000 | 0.84 % | |
| 829 321 | 0.82 % | ||
| First Partners Holding 16 AS Total 20 largest shareholders Others |
76 572 259 25 162 799 |
75.27 % 24.73 % |
Biofish Holding AS had a total of 101 735 058 shares issued at 30 September 2024.
Interest bearing debt totalling NOK 50 000 000 is due in January 2027.
The loan has quarterly instalments of NOK 1 000 000.
The Group has a bank overdraŌ facility of NOK 33 000 000, of which NOK 10 000 000 was drawn at 30 September 2024.
Deferred tax asset of NOK 12 300 000 at 30 September 2024 has not been recognised in the balance sheet as the Group has been in a start-and build-up phase.

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.